Stay updated on AT1001 Long-term Safety Study in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.

Latest updates to the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page
- Check2 days agoChange DetectedA site-wide funding status notice was added and the site version updated to v3.4.1, replacing v3.4.0. No study data, core content, or eligibility details were changed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check9 days agoChange DetectedAdded a glossary toggle and updated footer/metadata labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0); core study content remains unchanged.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision metadata updated to v3.3.4; no study content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedLocations section now lists Georgia, New York, and Texas under Locations. The HHS Vulnerability Disclosure link was removed and the revision tag updated from v3.3.2 to v3.3.3.SummaryDifference0.5%

- Check72 days agoChange DetectedRevision: v3.2.0 removed and v3.3.2 added; no core content or trial details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedThe government funding status notice at the top of the ClinicalTrials.gov page was removed.SummaryDifference0.4%

Stay in the know with updates to AT1001 Long-term Safety Study in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.